Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Gross Margin Over TimeExpanding
Percentile Rank43
3Y CAGR-0.7%
5Y CAGR-0.4%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
-0.7%/yr
Annual compound
5Y CAGR
-0.4%/yr
Consistent
Percentile
P43
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM98.05%+148.1%
2024-203.96%+48.6%
2023-396.85%-496.8%
2022100.00%+0.3%
202199.68%-0.3%
2020100.00%-
20190.00%-
20180.00%-100.0%
2017100.00%0.0%
2016100.00%-